Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Comprehensive Characterization of Secondary Metabolites from Colebrookea oppositifolia (Smith) Leaves from Nepal and Assessment of Cytotoxic Effect and Anti-Nf-κB and AP-1 Activities In Vitro

G. Peron, J. Hošek, G. Prasad Phuyal, D. Raj Kandel, R. Adhikari, S. Dall'Acqua

. 2020 ; 21 (14) : . [pub] 20200711

Language English Country Switzerland

Document type Journal Article

Here we report the comprehensive characterization of the secondary metabolites from the leaves of Colebrookea oppositifolia Smith, a species used as medicinal plant in the traditional medicine of Nepal. Phytochemical screening of bioactives was performed using an integrated LC-MSn and high resolution MS (Mass Spectrometry) approach. Forty-three compounds were tentatively identified, mainly aglyconic and glycosilated flavonoids and phenolic acids, as well as other bioactives such as coumarins and terpenes were detected. Furthermore, the NF-κB and AP-1 inhibitory activity of C. oppositifolia extract were evaluated, as well as its cytotoxicity against THP-1 cells, in order to assess the potential use of this herb as a source of anti-inflammatory and cytotoxic compounds. The results so far obtained indicate that C. oppositifolia leaves extract could significantly reduce the viability of THP-1 cells (IC50 = 6.2 ± 1.2 µg/mL), as well as the activation of both NF-κB and AP-1 at the concentration of 2 μg/mL. Our results indicate that Nepalese C. oppositifolia is a valuable source of anti-inflammatory and cytotoxic compounds. The phytochemical composition reported here can partially justify the traditional uses of C. oppositifolia in Nepal, especially in the treatment of inflammatory diseases, although further research will be needed to assess the full potential of this species.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21012367
003      
CZ-PrNML
005      
20210507102628.0
007      
ta
008      
210420s2020 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms21144897 $2 doi
035    __
$a (PubMed)32664524
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Peron, Gregorio $u Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Via Marzolo 5, 35131 Padova, Italy
245    10
$a Comprehensive Characterization of Secondary Metabolites from Colebrookea oppositifolia (Smith) Leaves from Nepal and Assessment of Cytotoxic Effect and Anti-Nf-κB and AP-1 Activities In Vitro / $c G. Peron, J. Hošek, G. Prasad Phuyal, D. Raj Kandel, R. Adhikari, S. Dall'Acqua
520    9_
$a Here we report the comprehensive characterization of the secondary metabolites from the leaves of Colebrookea oppositifolia Smith, a species used as medicinal plant in the traditional medicine of Nepal. Phytochemical screening of bioactives was performed using an integrated LC-MSn and high resolution MS (Mass Spectrometry) approach. Forty-three compounds were tentatively identified, mainly aglyconic and glycosilated flavonoids and phenolic acids, as well as other bioactives such as coumarins and terpenes were detected. Furthermore, the NF-κB and AP-1 inhibitory activity of C. oppositifolia extract were evaluated, as well as its cytotoxicity against THP-1 cells, in order to assess the potential use of this herb as a source of anti-inflammatory and cytotoxic compounds. The results so far obtained indicate that C. oppositifolia leaves extract could significantly reduce the viability of THP-1 cells (IC50 = 6.2 ± 1.2 µg/mL), as well as the activation of both NF-κB and AP-1 at the concentration of 2 μg/mL. Our results indicate that Nepalese C. oppositifolia is a valuable source of anti-inflammatory and cytotoxic compounds. The phytochemical composition reported here can partially justify the traditional uses of C. oppositifolia in Nepal, especially in the treatment of inflammatory diseases, although further research will be needed to assess the full potential of this species.
650    _2
$a antiflogistika $x izolace a purifikace $x farmakologie $x toxicita $7 D000893
650    _2
$a chromatografie kapalinová $7 D002853
650    _2
$a flavonoidy $x analýza $x izolace a purifikace $7 D005419
650    _2
$a lidé $7 D006801
650    _2
$a hydroxybenzoáty $x analýza $x izolace a purifikace $7 D062385
650    _2
$a hluchavkovité $x metabolismus $7 D019686
650    _2
$a hmotnostní spektrometrie $7 D013058
650    _2
$a metabolom $7 D055442
650    _2
$a methanol $7 D000432
650    _2
$a NF-kappa B $x antagonisté a inhibitory $7 D016328
650    _2
$a rostlinné extrakty $x chemie $x izolace a purifikace $x farmakologie $x toxicita $7 D010936
650    _2
$a listy rostlin $x metabolismus $7 D018515
650    _2
$a léčivé rostliny $x metabolismus $7 D010946
650    _2
$a THP-1 buňky $7 D000074084
650    _2
$a transkripční faktor AP-1 $x antagonisté a inhibitory $7 D018808
651    _2
$a Nepál $7 D009390
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hošek, Jan $u Division of Biologically Active Complexes and Molecular Magnets, Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacký University in Olomouc, Šlechtitelů 27, 78371 Olomouc, Czech Republic
700    1_
$a Prasad Phuyal, Ganga $u Research Centre for Applied Science and Technology, Tribhuvan University, Kiritipur, 44613 Kathmandu, Nepal
700    1_
$a Raj Kandel, Dharma $u Research Centre for Applied Science and Technology, Tribhuvan University, Kiritipur, 44613 Kathmandu, Nepal
700    1_
$a Adhikari, Rameshwar $u Research Centre for Applied Science and Technology, Tribhuvan University, Kiritipur, 44613 Kathmandu, Nepal
700    1_
$a Dall'Acqua, Stefano $u Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Via Marzolo 5, 35131 Padova, Italy
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 21, č. 14 (2020)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32664524 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20210507102627 $b ABA008
999    __
$a ok $b bmc $g 1650689 $s 1132746
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 21 $c 14 $e 20200711 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
LZP    __
$a Pubmed-20210420

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...